New Drug ApprovalDupixent Breaks New Ground in Pediatric Chronic Urticaria Care Dupixent Breaks New Ground in Pediatric Chronic Urticaria Care Read Post »
Health Tidings Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv Acquisition Amneal Bets Big on Biosimilars with Kashiv Acquisition Read Post »
Health TidingsModerna Steps Up the Guard with Phase 3 Trial for Bird Flu Vaccine Moderna Steps Up the Guard with Phase 3 Trial for Bird Flu Vaccine Read Post »
Health TidingsFDA Extends the Runway for Sarclisa SC Approval Decision FDA Extends the Runway for Sarclisa SC Approval Decision Read Post »
New Drug ApprovalTzield pushes back the clock on T1D in young children with FDA nod Tzield pushes back the clock on T1D in young children with FDA nod Read Post »
Clinical TrialsNeurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Neurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Read Post »
Clinical TrialsJohnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Johnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Read Post »
New Drug ApprovalIpsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Ipsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Read Post »
Health TidingsInhibrx Reports Positive CRC Data for Ozekibart Inhibrx Reports Positive CRC Data for Ozekibart Read Post »
Mergers & AcquisitionsMerck Builds AI-Enabled Enterprise with Support from Google Cloud Merck Builds AI-Enabled Enterprise with Support from Google Cloud Read Post »
Health Tidings¥700 Million GHIT Funding Targets Innovative Treatments for Falciparum and... ¥700 Million GHIT Funding Targets Innovative Treatments for Falciparum and... Read Post »
Clinical TrialsRoche Advances a New Front in MS Treatment Roche Advances a New Front in MS Treatment Read Post »
Clinical TrialsENSPRYNG Signals a Breakthrough for Roche in MOGAD ENSPRYNG Signals a Breakthrough for Roche in MOGAD Read Post »
Regulatory & Health PolicyNICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer NICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer Read Post »
New Drug ApprovalMerck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Merck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Read Post »
Health Tidings Mergers & AcquisitionsCompass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Compass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Read Post »
Clinical TrialsAfter the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path After the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path Read Post »
Health TidingsRegulatory Update Expected for LYTENAVA™ in May Regulatory Update Expected for LYTENAVA™ in May Read Post »
Clinical TrialsMerck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Merck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Read Post »
Clinical TrialsAstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... AstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... Read Post »
New Drug ApprovalEU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... EU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... Read Post »
Health TidingsImmunityBio Launches ANKTIVA in Saudi Arabia for Bladder and Lung Cancer ImmunityBio Launches ANKTIVA in Saudi Arabia for Bladder and Lung Cancer Read Post »
Health TidingsOtsuka Unit Taiho Halts Phase 3 STAR-121 Trial After Futility Analysis Otsuka Unit Taiho Halts Phase 3 STAR-121 Trial After Futility Analysis Read Post »
New Drug ApprovalBlenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Blenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Read Post »
Health TidingsLantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in... Lantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in... Read Post »
Health TidingsRoche Pushes Gazyva Across the Regulatory Finish Line in SLE Roche Pushes Gazyva Across the Regulatory Finish Line in SLE Read Post »
Clinical TrialsBicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Bicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Read Post »
Clinical TrialsLundbeck Highlights Brain Fog Improvements with Eptinezumab Lundbeck Highlights Brain Fog Improvements with Eptinezumab Read Post »
Clinical TrialsAstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD AstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD Read Post »
Health TidingsFDA Priority Review Granted to KEYTRUDA Combinations in MIBC Based on Phase... FDA Priority Review Granted to KEYTRUDA Combinations in MIBC Based on Phase... Read Post »
Health TidingsDose Mix-Up Triggers Recall of Ramipril Capsules in UK Dose Mix-Up Triggers Recall of Ramipril Capsules in UK Read Post »
Clinical TrialsNew data from United Therapeutics points to earlier action in pulmonary hyp... New data from United Therapeutics points to earlier action in pulmonary hyp... Read Post »
Clinical TrialsXenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Xenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Read Post »
Health Tidings Mergers & AcquisitionsBiogen Takes Full Control of Felzartamab from TJ Biopharma Biogen Takes Full Control of Felzartamab from TJ Biopharma Read Post »
ManufacturingAskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase I... AskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase I... Read Post »
Clinical TrialsNovo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Novo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Read Post »
GenericsANI Pharmaceuticals Rolls Out Generic Pimozide, Gains 180-Day Edge ANI Pharmaceuticals Rolls Out Generic Pimozide, Gains 180-Day Edge Read Post »
Health TidingsPasithea Therapeutics Secures FDA Rare Pediatric Disease Designation for NF... Pasithea Therapeutics Secures FDA Rare Pediatric Disease Designation for NF... Read Post »
GenericsAlembic, Aurobindo Secure USFDA ANDA Approvals Alembic, Aurobindo Secure USFDA ANDA Approvals Read Post »
Health Tidings Regulatory & Health PolicyFederal Order Expands Access and Research for Psychedelic Therapies Federal Order Expands Access and Research for Psychedelic Therapies Read Post »
ResearchZai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Zai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Read Post »
ResearchWhat Is the Optimal Time to Take Statins: Morning or Evening? What Is the Optimal Time to Take Statins: Morning or Evening? Read Post »
Clinical TrialsSanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Sanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Read Post »
Clinical TrialsModerna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Moderna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Read Post »
Health TidingsVYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDP VYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDP Read Post »
Health Tidings Mergers & AcquisitionsUCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move UCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move Read Post »
New Drug ApprovalShifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Shifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Read Post »
Clinical TrialsZai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Zai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Read Post »
Clinical TrialsNuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Nuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Read Post »
